In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei

Author： Drago M. Scaltrito M. Morace G.

Publisher： Springer Publishing Company

ISSN： 0934-9723

Source： European Journal of Clinical Microbiology and Infectious Diseases, Vol.23, Iss.8, 2004-08, pp. : 619-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular analysis of Candida glabrata clinical isolates

By Berila Norbert Subik Julius

Mycopathologia, Vol. 170, Iss. 2, 2010-08 ,pp. : 99-105

Springer Publishing Company

Access to resources Recommend Favorite

Candida krusei: biotechnological potentials and concerns about its safety

By Yadav Jay Shankar Singh Bezawada Jyothi Yan Song Tyagi R.D. Surampalli R.Y.

Canadian Journal of Microbiology, Vol. 58, Iss. 8, 2012-08 ,pp. : 937-952

NRC Research Press

Access to resources Recommend Favorite

Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study

By Majoros L. Szegedi I. Kardos G. Erdész C. Kónya J. Kiss C.

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 25, Iss. 12, 2006-12 ,pp. : 803-806

Springer Publishing Company

Access to resources Recommend Favorite

In vitro activity of eugenol against Candida albicans biofilms

By He Miao Du Minquan Fan Mingwen Bian Zhuan

Mycopathologia, Vol. 163, Iss. 3, 2007-03 ,pp. : 137-143

Springer Publishing Company

Access to resources Recommend Favorite

Antifungal Activity of Baicalein Against Candida krusei Does Not Involve Apoptosis

By Kang Kai Fong Wing-Ping Tsang Paul

Mycopathologia, Vol. 170, Iss. 6, 2010-12 ,pp. : 391-396

Springer Publishing Company

Access to resources Recommend Favorite